| Identification | More | [Name]
BIS(2-METHOXYETHYL)AMINE | [CAS]
111-95-5 | [Synonyms]
2,2'-DIMETHOXYDIETHYLAMINE
BIS(2-METHOXYETHYL)AMINE
2-methoxy-n-(2-methoxyethyl)-ethanamin
2-methoxy-N-(2-methoxyethyl)-Ethanamine
Bis(2-methoxyethyl)amine, 98+% | [EINECS(EC#)]
203-923-9 | [Molecular Formula]
C6H15NO2 | [MDL Number]
MFCD00025906 | [Molecular Weight]
133.19 | [MOL File]
111-95-5.mol |
| Chemical Properties | Back Directory | [Melting point ]
<-60°C | [Boiling point ]
170-172 °C(lit.)
| [density ]
0.902 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.419(lit.)
| [Fp ]
137 °F
| [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [Water Solubility ]
Completely miscible in water | [form ]
clear liquid | [pka]
8.67±0.19(Predicted) | [color ]
Colorless to Light orange to Yellow | [BRN ]
1736313 | [InChI]
1S/C6H15NO2/c1-8-5-3-7-4-6-9-2/h7H,3-6H2,1-2H3 | [InChIKey]
IBZKBSXREAQDTO-UHFFFAOYSA-N | [SMILES]
COCCNCCOC | [LogP]
-0.373 (est) | [CAS DataBase Reference]
111-95-5(CAS DataBase Reference) | [EPA Substance Registry System]
Ethanamine, 2-methoxy-N-(2-methoxyethyl)- (111-95-5) |
| Safety Data | Back Directory | [Hazard Codes ]
C | [Risk Statements ]
R34:Causes burns. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [RIDADR ]
UN 2734 8/PG 2
| [WGK Germany ]
3
| [F ]
34 | [TSCA ]
TSCA listed | [HazardClass ]
8 | [PackingGroup ]
II | [HS Code ]
29221990 | [Storage Class]
3 - Flammable liquids | [Hazard Classifications]
Acute Tox. 4 Dermal
Eye Dam. 1
Flam. Liq. 3
Skin Corr. 1B |
| Hazard Information | Back Directory | [Uses]
Bis(2-methoxyethyl)amine is used to prepare pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of cyclin-dependent kinases 4 and 6. It is also used to synthesize (pyridyl)pyrazolopyrimidines as corticotropin-releasing factor receptor antagonists. |
|
|